Bharat Parenterals (NSE:BPLPHARMA) Common Stock: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BPLPHARMA Bharat Parenterals Ltd NSE:BPLPHARMA
55 GF Score
Price ₹1,294.70
GF Value ₹1,232.25
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Bharat Parenterals Common Stock?

Bharat Parenterals NSE:BPLPHARMA +1.60% 55 Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:BPLPHARMA with a GF Score™ of 55/100 and a GF Value™ of ₹1,232.25 (Fairly Valued). The stock has 5 warning signs investors should review.

Bharat Parenterals's quarterly common stock increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹69 Mil) but then declined from Mar. 2026 (₹69 Mil) to Jun. 2026 (₹0 Mil).

Bharat Parenterals's annual common stock increased from Mar. 2024 (₹58 Mil) to Mar. 2025 (₹69 Mil) but then stayed the same from Mar. 2025 (₹69 Mil) to Mar. 2026 (₹69 Mil).

Bharat Parenterals Common Stock Historical Data

* Premium members only.

The historical data trend for Bharat Parenterals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Parenterals Common Stock Chart

Bharat Parenterals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.75 57.75 58.20 68.92 68.92

Bharat Parenterals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 68.90 0.00 68.92 0.00
NSE:BPLPHARMA
55GF Score
Bharat Parenterals Ltd NSE:BPLPHARMA
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Parenterals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹0 Mil mean?
Bharat Parenterals (NSE:BPLPHARMA) has a Common Stock of ₹0 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bharat Parenterals and its competitors.
Is Bharat Parenterals' Common Stock too high?
Bharat Parenterals' current Common Stock is ₹0 Mil. Overall, Bharat Parenterals has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bharat Parenterals' Common Stock compare to ?
Bharat Parenterals' Common Stock of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bharat Parenterals and its competitors. Bharat Parenterals's current Common Stock is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Parenterals stock overvalued right now?
Based on GuruFocus' analysis, Bharat Parenterals (NSE:BPLPHARMA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,232.25, compared to a current price of ₹1,294.70 — trading 5.1% above its estimated fair value. The current Common Stock is ₹0 Mil. Bharat Parenterals' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Bharat Parenterals (NSE:BPLPHARMA), the current Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bharat Parenterals (NSE:BPLPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Bharat Parenterals stock appears to be overvalued. The current stock price of ₹1,294.70 is trading 5.1% above its estimated GF Value™ of ₹1,232.25. GuruFocus considers Bharat Parenterals to be Fairly Valued.

Key valuation signals for NSE:BPLPHARMA:

  • Common Stock: ₹0 Mil
  • GF Value™: ₹1,232.25 vs. price of ₹1,294.70 (5.1% above fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the NSE:BPLPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bharat Parenterals Business Description

Comparable Companies
Other Exchanges 541096:India
Address Survey No.144-A, Jarod Samlaya Road, Village Haripura, Tehsil Savli, Vadodara, GJ, IND, 391520
Bharat Parenterals Ltd is a pharmaceutical company. It provides various products such as Capsules, Dry Syrups, Sachets, Oral Liquids, Injections, Semisolids, and others. Geographically, the group has a business presence in India and Outside India.
55GF Score

Get the complete analysis for NSE:BPLPHARMA

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,294.70
Price
₹1,232.25
GF Value